| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/10/2006 | CA2352554C Substituted benzimidazoles and their use as parp inhibitors |
| 10/10/2006 | CA2350734C 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 10/10/2006 | CA2347939C Composition for the treatment of rheumatism, hepatitis or pancreatitis |
| 10/10/2006 | CA2338415C Preparation of thioarabinofuranosyl compounds and use thereof |
| 10/10/2006 | CA2336682C Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
| 10/10/2006 | CA2336000C N-substituted piperazines and 1,4-disubstituted piperidines |
| 10/10/2006 | CA2321909C Product and method to reduce stress induced immune suppression |
| 10/10/2006 | CA2307303C Prolonged-action eye drop |
| 10/10/2006 | CA2306333C Oral morphine multiparticulate formulation |
| 10/10/2006 | CA2291233C Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents |
| 10/10/2006 | CA2290521C Medicinal aerosol products |
| 10/10/2006 | CA2285477C Formulations and methods to treat and prevent equine protozoal myeloencephalitis |
| 10/10/2006 | CA2280730C Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders |
| 10/10/2006 | CA2279842C Method and apparatus for the coating of substrates for pharmaceutical use |
| 10/10/2006 | CA2274594C Aminopyrazole derivatives |
| 10/10/2006 | CA2268968C Iminochlorin aspartic acid derivatives |
| 10/10/2006 | CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same |
| 10/10/2006 | CA2255951C Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 10/10/2006 | CA2255064C Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
| 10/10/2006 | CA2253407C Inorganic ion receptor-active compounds |
| 10/10/2006 | CA2252038C Buccal polar spray or capsule |
| 10/10/2006 | CA2238277C Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 10/10/2006 | CA2237056C Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 10/10/2006 | CA2231292C Method for decreasing ldl-cholesterol concentration and increasing hdl-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease |
| 10/10/2006 | CA2228393C Use of adamantane derivatives for treating diseases of the inner ear |
| 10/10/2006 | CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 10/10/2006 | CA2224912C Method for promoting ovulation, parturition, and lactation in mammals |
| 10/10/2006 | CA2223594C Myogenic differentiation of human mesenchymal stem cells |
| 10/10/2006 | CA2219678C Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection or associated diseases |
| 10/10/2006 | CA2214418C Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 10/10/2006 | CA2211889C Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines |
| 10/10/2006 | CA2207323C Use of pramipexole as a neuroprotective agent |
| 10/10/2006 | CA2196640C Substituted quinazoline derivatives |
| 10/10/2006 | CA2158862C Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 10/10/2006 | CA2157905C Process for purifying taxoids |
| 10/10/2006 | CA2152191C Therapeutic agent for glaucoma and ocular hypotensive agent |
| 10/10/2006 | CA2150804C Antiallergic triazolo(pyrrolo, thieno or furano)azepine derivatives |
| 10/10/2006 | CA2122431C Topical administration of vitamin d to mammals and compositions therefor |
| 10/10/2006 | CA2113623C Use of quinolizine derivatives as orexigenics |
| 10/09/2006 | WO2006110473A2 Phospholipid-based pharmaceutical formulations and methods for producing and using same |
| 10/09/2006 | CA2603462A1 Phospholipid-based pharmaceutical formulations and methods for producing and using same |
| 10/08/2006 | CA2503310A1 Method of activation of cannabis to render standardized preparations for therapeutic administration, other than smoking |
| 10/07/2006 | CA2516873A1 Method for preventing or treating respiratory infections in infants |
| 10/05/2006 | WO2006105507A2 Indoloquinone tumor radiation sensitization |
| 10/05/2006 | WO2006105482A2 Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same |
| 10/05/2006 | WO2006105481A1 Low-concentration capsaicin patch and methods for treating neuropathic pain |
| 10/05/2006 | WO2006105442A2 Spirocyclic heterocyclic derivatives and methods of their use |
| 10/05/2006 | WO2006105399A1 Methods for administering ixabepilone |
| 10/05/2006 | WO2006105374A2 Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue |
| 10/05/2006 | WO2006105372A2 Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors |
| 10/05/2006 | WO2006105313A2 Compositions of and methods of using oversulfated glycosaminoglycans |
| 10/05/2006 | WO2006105304A2 Phenyl and pyridyl lta4h modulators |
| 10/05/2006 | WO2006105289A1 Bicyclic pyrazole compounds as antibacterial agents |
| 10/05/2006 | WO2006105262A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl |
| 10/05/2006 | WO2006105237A2 Inhibitors for extracellular signal-regulated kinase docking domains and uses therefor |
| 10/05/2006 | WO2006105222A2 Carboxamide inhibitors of tgfb |
| 10/05/2006 | WO2006105221A1 2-METHYLENE-19-NOR-(23S)-25-DEHYDRO-1α-HYDROXYVITAMIN D3-26,23-LACTONE AND 2-METHYLENE-19-NOR-(23R)-25-DEHYDRO-1α-HYDROXYVITAMIN D3-26,23-LACTONE |
| 10/05/2006 | WO2006105217A2 Spirocyclic thrombin receptor antagonists |
| 10/05/2006 | WO2006105216A1 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment |
| 10/05/2006 | WO2006105196A2 Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health |
| 10/05/2006 | WO2006105194A2 Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application |
| 10/05/2006 | WO2006105167A2 Methods, compositions, and formulations for preventing or reducing adverse effects in a patient |
| 10/05/2006 | WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors |
| 10/05/2006 | WO2006105112A2 Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people |
| 10/05/2006 | WO2006105063A1 Heterobicylic inhibitors of tgfbeta |
| 10/05/2006 | WO2006105058A2 Trihydroxy polyunsaturated eicosanoid derivatives |
| 10/05/2006 | WO2006105035A2 Muscarinic modulators |
| 10/05/2006 | WO2006105023A1 Pyridine derivatives useful as inhibitors of pkc-theta |
| 10/05/2006 | WO2006105019A1 Compounds and methods for treating seizure disorders |
| 10/05/2006 | WO2006104997A2 Tartaric acid salts of a dipeptidyl peptidase-iv inhibitor |
| 10/05/2006 | WO2006104983A1 Therapeutic methods for type i diabetes |
| 10/05/2006 | WO2006104975A2 Modulation of telomere length in telomerase positive cells and cancer therapy |
| 10/05/2006 | WO2006104971A1 Atp competitive kinase inhibitors |
| 10/05/2006 | WO2006104945A2 Hepatitis c therapies |
| 10/05/2006 | WO2006104917A2 Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives |
| 10/05/2006 | WO2006104915A2 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS |
| 10/05/2006 | WO2006104892A2 Morinda citrifolia based antifungal formulations and methods |
| 10/05/2006 | WO2006104889A2 Novel compounds |
| 10/05/2006 | WO2006104791A1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
| 10/05/2006 | WO2006104762A2 Method of treating men with testosterone supplement and 5alpha-reductase inhibitor |
| 10/05/2006 | WO2006104751A2 Methods and compositions for modulating rho-mediated gene transcription |
| 10/05/2006 | WO2006104715A1 Prokineticin 1 receptor antagonists |
| 10/05/2006 | WO2006104713A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 10/05/2006 | WO2006104686A1 Piperazinyl substituted cyclohexane 1,4-diamines |
| 10/05/2006 | WO2006104676A1 Ganglionic blocking agents for the treatment of epithelial diseases |
| 10/05/2006 | WO2006104668A2 Composition and methods for the treatment of proliferative diseases |
| 10/05/2006 | WO2006104667A2 Novel method |
| 10/05/2006 | WO2006104646A1 Hiv protease inhibitors |
| 10/05/2006 | WO2006104594A2 Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors |
| 10/05/2006 | WO2006104564A1 A method for preventing and/or treating vaginal and vulval infections |
| 10/05/2006 | WO2006104406A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
| 10/05/2006 | WO2006104402A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104401A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104400A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104399A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104398A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104397A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104396A1 Pre-complexed copper antagonist compositions |
| 10/05/2006 | WO2006104369A1 Novel use of lignan compounds |
| 10/05/2006 | WO2006104289A1 Pharmaceutical composition for inhibition of tumor growth |